MedTrace Logo

Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection

NCT04466982 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2025-06-29

No results posted yet for this study

Summary

This study is designed to investigate the acuity of olfactory dysfunction in COVID-19 positive patients in the United Kingdom. In particular defining severity with objective testing and determining if this has any predictive value on the outcome of the SARS CoV-2 infection. In addition, this study will strive to determine duration / natural history of olfactory dysfunction in these patients in respect to a positive SARS CoV-2 diagnosis. It should also demonstrate the impact of olfactory dysfunction on patient Quality of Life (QOL).

Conditions

  • Olfactory Disorder
  • COVID19
  • SARS-CoV-2
  • Anosmia
  • Microsomia
  • Smell Disorder
  • Quality of Life

Sponsors & Collaborators

  • Imperial College Healthcare NHS Trust

    collaborator OTHER

  • Royal Cornwall Hospitals Trust

    collaborator OTHER

  • Cambridge University Hospitals NHS Foundation Trust

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-02
Primary Completion
2022-12-30
Completion
2023-03-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04466982 on ClinicalTrials.gov